✦ LIBER ✦

Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy

✍ Scribed by Planas Morin, J.; Celma Domenech, A.; Placer Santos, J.; Trilla Herrera, E.; Salvador Lacambra, C.; Lorente Garcia, D.; Regis, L.; Carles Galceran, J.; Morote Robles, J.

Book ID: 125344662
Publisher: Springer
Year: 2014
Tongue: English
Weight: 289 KB
Volume: 34
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-014-2977-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP70-04 BONE MASS BEHAVIOR AFTER ONE YEA

MP70-04 BONE MASS BEHAVIOR AFTER ONE YEAR OF DIFFERENT TREATMENT STRATEGIES IN PROSTATE CANCER PATIENTS SUBJECTED TO ANDROGEN DEPRIVATION THERAPY

✍ Planas, Jacques; Celma, Ana; Placer, Jose; Salvador, Carles; Trilla, Enrique; Lo 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 553 KB

Loss of bone mass in patients with prost

Loss of bone mass in patients with prostate cancer subjected to androgenic deprivation

✍ J. Morote; J. Planas 📂 Article 📅 2011 🏛 Elsevier ⚖ 380 KB

611 poster ANDROGEN DEPRIVATION THERAPY

611 poster ANDROGEN DEPRIVATION THERAPY (ADT) FOR SALVAGE TREATMENT OF PSA ONLY RECURRENT PROSTATE CANCER AFTER INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER : MEDIAN 6 YEAR FOLLOW-UP IN 26 PATIENTS

✍ I. Garcia; R. Mark; R. Akins; M. Nair 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Differences in Time to Disease Progressi

Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12Years of Follow-up

✍ Kibel, A.S. 📂 Article 📅 2014 🏛 Elsevier Science ⚖ 46 KB